JAZZ - Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q1 2022 Results - Earnings Call Transcript

Jazz Pharmaceuticals plc (JAZZ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Andrea Flynn – Head-Investor Relations Bruce Cozadd – Chairman and Chief Executive Officer Dan Swisher – President Rob Iannone – Executive Vice President, Global Head-R&D Renee Gala – Executive Vice President and Chief Financial Officer Kim Sablich – Executive Vice President and General Manager-North America Conference Call Participants Ken Cacciatore – Cowen Jessica Fye – JPMorgan Jason Gerberry – Bank of America Marc Goodman – SVB Leerink Brandon Folkes – Cantor Fitzgerald Jeff Hung – Morgan Stanley Balaji Prasad – Barclays Rob Palermo – Goldman Sachs Gary Nachman – BMO Capital Markets David Amsellem – Piper Sandler Annabel Samimy – Stifel Oren Livnat – H. C. Wainwright Greg Fraser – Truist Securities Presentation Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Jazz Pharmaceuticals First Quarter 2022

For further details see:

Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q1 2022 Results - Earnings Call Transcript